December 10, 2025

This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children

Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing

The Medicine Maker

December 09, 2025

Dental care utilization stagnant among Medicaid beneficiaries

Children's dental care utilization remains stagnant, raising concerns about gaps in access to care, particularly among Medicaid beneficiaries. (Noah Levine)

ADA News

November 26, 2025

Is Prevention Always Better Than Cure?

German discussion paper calls for greater balance between preventative and curative measures for childhood blindness

The Ophthalmologist

November 20, 2025

New study finds U.S. fluoride exposure linked to better adolescent cognitive performance 

A new study finds typical childhood fluoride exposure is linked to modestly better teen cognitive performance with no later cognitive harm.

ADA News

November 19, 2025

FDA Approves Selumetinib for Adults With NF1 With Symptomatic, Inoperable Plexiform Neurofibromas

The MEK inhibitor was approved today for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. In September 2025, the FDA approved selumetinib capsules a...

The ASCO Post

November 11, 2025

Advancing Gene Therapy for Canavan Disease

Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach

The Medicine Maker

November 01, 2025

In the World of Anti-Myopia Spectacles, Where Does Ortho-k Fit into My Practice?

The FDA's approval of anti-myopia spectacles opens new doors for myopia management, prompting a shift in approach among eye care professionals, as discussed by Dr. Sheila Morrison.

Contact Lens Spectrum

October 31, 2025

FDA to restrict sale of fluoride supplements, halting previously promised ban

The FDA announced that it plans to restrict the sale of unapproved ingestible fluoride prescription drug products for children.  

ADA News

October 30, 2025

Summarizing the Big Events in the Small Molecules Field

October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.

The Medicine Maker